Bio-Techne Q1 revenue $289.5M (organic +4%), adj EPS $0.42; declares $0.08 dividend

BIO-TECHNE Corp

2025-Q1 EPS reported $0.21 revenue$289,458,000

Q1 revenue $289.5M, up 5% reported (4% organic); GAAP EPS $0.21 vs $0.31; adjusted EPS $0.42 vs $0.41.
Diagnostics & Spatial Biology segment organic growth 14%; cell and gene therapy workflow solutions strong.
Dividend of $0.08 per share declared, payable Nov 22 to holders of record Nov 11.
Annual meeting: board set at 9, all director nominees elected, say-on-pay approved, KPMG ratified.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.